Literature DB >> 9577492

Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.

P D Shreve1, R S Steventon, E C Deters, P V Kison, M D Gross, R L Wahl.   

Abstract

PURPOSE: To compare the performance of a dual-head single photon emission computed tomographic (SPECT) Anger camera operated in coincidence mode with that of a dedicated positron emission tomographic (PET) scanner in the imaging of cancer with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG).
MATERIALS AND METHODS: Thirty-one patients with known or suspected malignant neoplasms underwent imaging with both methods, and the images were read blindly. Diagnostic performance on a lesion-by-lesion basis was compared with attenuation-corrected PET as the standard of reference.
RESULTS: Of a total of 109 discrete lesions depicted at PET, 60 (relative sensitivity, 55%) were identified on the coincidence-mode images. Of the nodules or masses depicted at PET, 13 (93%) of 14 lung nodules or masses, 20 (65%) of 31 mediastinal lymph nodes, five (71%) of seven lesions in the neck, five (55%) of nine axillary lymph nodes, 11 (50%) of 22 bone metastases, and six (23%) of 26 abdominal tumor deposits were correctly identified on the coincidence gamma camera images.
CONCLUSION: These preliminary findings indicate FDG imaging with a modified dual-detector gamma camera operating in coincidence mode can depict many of the lesions depicted with a PET scanner, particularly in the lungs. Sensitivity for lesions detected at dedicated FDG PET was poor in the abdomen and in all locations outside the lungs for tumor deposits generally less than 1.5 cm in short-axis diameter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577492     DOI: 10.1148/radiology.207.2.9577492

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

Review 1.  Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives.

Authors:  D Visvikis; P J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-13       Impact factor: 9.236

2.  FDG-PET: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

3.  Brain fluorine-18 fluorodeoxyglucose imaging with dual-head coincidence gamma camera: comparison with dedicated ring-detector positron emission tomography.

Authors:  K Fukuchi; K Hayashida; H Moriwaki; K Fukushima; N Kume; T Katafuchi; M Sago; M Takamiya; Y Ishida
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

4.  Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma.

Authors:  Tatsuo Torizuka; Fumitoshi Nakamura; Toshihiko Kanno; Masami Futatsubashi; Etsuji Yoshikawa; Hiroyuki Okada; Masahide Kobayashi; Yasuomi Ouchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-22       Impact factor: 9.236

5.  Spreadsheet program for estimating recovery coefficient to get partial volume corrected standardized uptake value in clinical positron emission tomography-computed tomography studies.

Authors:  Anil Kumar Pandey; Punit Sharma; Manjesh Pandey; Kk Aswathi; Arun Malhotra; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2012-04

Review 6.  Positron emission tomography scanning for the diagnosis and management of lung cancer.

Authors:  Bruce R Line; Charles S White
Journal:  Curr Treat Options Oncol       Date:  2004-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.